-
Founded in:
2012-06-26 -
Country:
China -
Address:
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing -
Tax NO.:
915000005992299001 -
Registered Funds:
450 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium levofolinate |
The pharmacological effects extracted from the above information are not clearly described
More
The pharmacological effects extracted from the above information are not clearly described |
80433-71-2 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Betamethasone 17-valerate |
Not yet clear
More
Not yet clear |
1mg | 2152-44-5 | 23 |
| Neomycin sulfate |
Not yet clear
More
Not yet clear |
3500unit | 1405-10-3 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-CAMPHOR |
It has the effects of promoting skin penetration and local analgesia
More
It has the effects of promoting skin penetration and local analgesia |
4% | 464-49-3 | 1 |
| DL-Menthol |
Used on the skin to produce a cooling sensation to relieve discomfort and pain
More
Used on the skin to produce a cooling sensation to relieve discomfort and pain |
3% | 89-78-1 | 8 |
| Methyl salicylate |
Topical application to joints or muscles may relieve pain
More
Topical application to joints or muscles may relieve pain |
2% | 119-36-8 | 18 |
| Diphenhydramine |
It has an antihistamine effect and can compete with histamine released from tissues for H1 receptors on effector cells, thereby treating allergic reactions
More
It has an antihistamine effect and can compete with histamine released from tissues for H1 receptors on effector cells, thereby treating allergic reactions |
1% | 58-73-1 | 3 |
| Chlorhexidine digluconate |
The diphenhydramine contained in this product is a derivative of ethanolamine, which has an antihistamine effect and can compete with histamine released from tissues for H1 receptors on effector cells, thereby treating allergic reactions. Camphor has a transdermal promotion effect and a local analgesic effect. Menthol is used on the skin to produce a cooling sensation to relieve discomfort and pain. Methyl salicylate can be used topically on joints or muscles to relieve pain. Glycyrrhetinic acid is an anti-inflammatory and antiallergic drug used to treat skin allergic diseases.
More
The diphenhydramine contained in this product is a derivative of ethanolamine, which has an antihistamine effect and can compete with histamine released from tissues for H1 receptors on effector cells, thereby treating allergic reactions. Camphor has a transdermal promotion effect and a local analgesic effect. Menthol is used on the skin to produce a cooling sensation to relieve discomfort and pain. Methyl salicylate can be used topically on joints or muscles to relieve pain. Glycyrrhetinic acid is an anti-inflammatory and antiallergic drug used to treat skin allergic diseases. |
0.2% | 18472-51-0 | 29 |
| 18β-Glycyrrhetinic Acid |
It is an anti-inflammatory and anti-allergic drug used to treat skin allergic diseases
More
It is an anti-inflammatory and anti-allergic drug used to treat skin allergic diseases |
0.3% | 471-53-4 | 5 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Penciclovir |
This product is a nucleoside antiviral drug, which has an inhibitory effect on type I and type II herpes simplex viruses in vitro. In virus-infected cells, viral thymidine deoxynucleoside kinase phosphorylates this product into penciclovir monophosphate, and then cellular kinase converts penciclovir monophosphate into penciclovir triphosphate. In vitro experiments have shown that penciclovir triphosphate and deoxyguanosine triphosphate competitively inhibit herpes simplex virus polymerase, thereby selectively inhibiting the synthesis and inhibition of herpes simplex virus DNA. The generation of herpes simplex virus mutants resistant to this product is due to changes in the properties of viral thymidine deoxynucleoside kinase or DNA polymerase. The most common acyclovir-resistant virus mutants lack thymidine kinase, and they are also resistant to this product.
More
This product is a nucleoside antiviral drug, which has an inhibitory effect on type I and type II herpes simplex viruses in vitro. In virus-infected cells, viral thymidine deoxynucleoside kinase phosphorylates this product into penciclovir monophosphate, and then cellular kinase converts penciclovir monophosphate into penciclovir triphosphate. In vitro experiments have shown that penciclovir triphosphate and deoxyguanosine triphosphate competitively inhibit herpes simplex virus polymerase, thereby selectively inhibiting the synthesis and inhibition of herpes simplex virus DNA. The generation of herpes simplex virus mutants resistant to this product is due to changes in the properties of viral thymidine deoxynucleoside kinase or DNA polymerase. The most common acyclovir-resistant virus mutants lack thymidine kinase, and they are also resistant to this product. |
39809-25-1 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin phosphate |
After absorption, it can be hydrolyzed into clindamycin to exert antibacterial effects, especially against Propionibacterium acnes. Topical use can also reduce epidermal fatty acids, which is beneficial for the treatment of acne.
More
After absorption, it can be hydrolyzed into clindamycin to exert antibacterial effects, especially against Propionibacterium acnes. Topical use can also reduce epidermal fatty acids, which is beneficial for the treatment of acne. |
24729-96-2 | 33 |